Jiang Xiaomeng: Resonance with Urban Development
Release time:
2021-08-11
"Jinhua daily" reporter Ji junlei
editor's note: in order to celebrate the centenary of the founding of the party, the organization department of the CPC Jinhua municipal Committee, Jinhua daily and Jinhua radio and television headquarters jointly planned and launched a special report on "100 years, 100 party members of all fields and ages in the city were selected in the form of one person, one short article and one micro-video, linking the moving moments that have taken place in the land of Bawu in the century since the founding of the Party. "Jiang Xiaomeng: Resonance with Urban Development at the Same Frequency" is the fourth article in the series of "Spring Tide Surge, Eight Wines First". In an interview with reporters, Jiang Xiaomeng, chairman of the group company, talked freely about personal development and enterprise symbiosis and co-prosperity, and peak development and Jinhua economy resonance and co-development from his more than 8 years of growth experience in peak work.
Based on the development of Jinhua, after the planned economy and the "Cultural Revolution" period, gradually entered the market economy, and there are not many enterprises that have achieved modern development. Jianfeng Group is one of the models. As a veteran enterprise with a history of63
years, under the leadership of Jiang Xiaomeng, Jianfeng Group is still full of vigor and vitality. "In the year of Jianfeng40 , I went from an ordinary front-line worker to the second-generation helmsman of the group, and witnessed its hard work, determined reform, independent innovation, and scientific development." Jiang Xiaomeng, chairman of Zhejiang Jianfeng Group Co., Ltd., said frankly that his personal development and enterprise symbiosis and co-prosperity. 1980
12
, Jiang Xiaomeng, who had just graduated from Senior high school, entered the then Jinhua County Cement Factory (the predecessor of Jianfeng Group) to work. At that time, Jinhua County Cement Factory was still in the stage of general kiln production line with more than,500 employees and annual cement production capacity of only ,10 tons. With the spring breeze of reform blowing all over China, the reform of China's state-owned enterprises has gradually started, and the external environment of peak development has undergone profound changes. Du Zihong, then director of the Peak Cement Plant, was keenly aware that the shortage of enterprise factors could be solved through institutional innovation, and the problem of resource constraints of the Peak Group could be solved through horizontal alliances with enterprises of different ownership. "Jianfeng Group increased its cement production capacity by 30
tons through horizontal integration in the mid -1980 s of the last century, which is equivalent to rebuilding3 Jinhua cement plants." 1987 5 January 15 , Jinhua Cement Factory united a number of enterprises and units to form Jianfeng Cement Group. In Jiang Xiaomeng's view, this is the first step for the peak to adapt to the transformation and upgrading of the internal and external environment, and it is in the forefront of the national cement industry. Soon, Peak Cement became famous in the market inside and outside the province. 1987 6
, Jiang Xiaomeng was selected by the State Council's Poverty Alleviation Leading Group to go to Dafang, Qianxi and other counties in Guizhou Province for technical poverty alleviation to help local cement factories improve product quality and production efficiency.1993 7 April 28 , Jianfeng Group was listed on the Shanghai Stock Exchange, becoming the first listed company in the national cement industry and the second listed company in Zhejiang Province, realizing the leapfrog development of Jianfeng Group. After that, Jianfeng Group entered the exploratory stage of diversified development, involving cement, medicine, transportation, electronics, cable and other fields. In 2004 , Jiang Xiaomeng served as the general manager of Jianfeng Group, and in 2007 , he served as the party secretary and chairman of Jianfeng Group. He conducted in-depth research and analysis on the economic situation and the development trend of the peak industry, put forward the management policy of "strengthening the main business through cooperation and innovation, standardizing science and seeking development", and led the enterprise to transform from diversified development to relatively diversified development and innovative development. Prior to this, he successively served as the general manager of Jianfeng Communication Cable Company and the general manager of Jianfeng Pharmaceutical, and has accumulated rich management experience in long-term practice. He has his own ideas about how to steer the big ship of the tip group.
In that year, Jiang Xiaomeng led Jianfeng Group and China Building Materials to integrate the cement sector business. Jianfeng Group, as one of the sponsor shareholders, participated in the establishment of Southern Cement Co., Ltd. and integrated some cement enterprises in the southeast economic zone through mergers and acquisitions and joint reorganization. Zhejiang Jianfeng Cement Co., Ltd., a subsidiary of Jianfeng Group, and Southern Cement Co., Ltd. jointly funded the establishment of Jinhua Nanfang Jianfeng Cement Co., Ltd. At the same time, Jianfeng Group's cement business, in line with the role of market niche, has successively laid out cement enterprises in Hubei, Yunnan, Guizhou and other regions with resources and markets, gradually establishing a leading position in China's cement industry. Jinhua's "peak cement" has become the golden business card of the whole province and even the whole country.
More importantly, Jianfeng Group and Jinhua City Development resonate at the same frequency. "It is no exaggeration to say that in the process of Jinhua's reform and opening up, Jianfeng Group has a leading role and provides a reference model for the development of many local enterprises." Jiang Xiaomeng said that Jianfeng Group has also actively contributed to the construction of Jinhua's urban infrastructure. The cement of Bayi Road, Shuanglong Street, Gymnasium, Jinwu Bridge, Shuanglong Bridge, and the municipal government were all from the city. Peak.
Jianfeng Group has another business that has to be mentioned, namely medicine. "Cement and medicine are two major industries that complement cyclical and non-cyclical, and they are also two carriages that drive the development of Jianfeng Group." While Jianfeng Group crossed the border from cement to medicine, Jiang Xiaomeng was also constantly learning medical knowledge. With this momentum, he obtained the qualification certificate of licensed pharmacist by himself, and was awarded the title of senior engineer at the professor level of pharmaceutical engineering, and became an expert in the field of medicine. At the same time, Jiang Xiaomeng also began to set up a management, R & D and sales team in the pharmaceutical industry, laying a solid foundation for the long-term and stable development of the enterprise. While doing a good job in business management, Jiang Xiaomeng has been working hard and has published more than 73 30 74 papers on new drug research and development and management in various journals at home and abroad over the years.
Under the leadership of Jiang Xiaomeng, Jianfeng Group has established a good long-term cooperative relationship with well-known universities and scientific research institutions such as China Pharmaceutical University and Shanghai Medical Institute, forming a provincial drug research institute, academician expert workstation, A three-in-one medical research and development system of post-doctoral workstations.
2003, "Jinhua's first 1.1 class of original new drugs-gatifloxacin and its preparation is developed by our peak, but also won the first prize of scientific and technological progress in Zhejiang Province, the R & D team won the honorary title of 'Zhejiang Province Model Collectives'. At present, the company has been granted 52
patents in the field of medicine, including43 invention patents." When he said this, Jiang Xiaomeng's face was full of pride. Walking on the streets of Jinhua, the peak pharmacy can be seen everywhere, which is the best proof that the enterprise develops products and serves the public. In recent years, Jianfeng Group has benefited from Jiang Xiaomeng's clear understanding and clear strategy, based on cement and medicine, and has continuously created the best performance in history. At present, the total assets of the company have increased by 48 times compared with that before listing, and the net assets have increased by 43 times. In 2019
, Jianfeng Group won the "Gold Quality" Sustainable Growth Award of Listed Companies. While the enterprise has achieved good benefits, he has also been recognized by the society. He has successively won special government allowances from the State Council, "Zhejiang Province's Second Outstanding Builders of Socialism with Chinese Characteristics", Zhejiang Province's outstanding contributions to young and middle-aged experts, and the first "Zhejiang Province" Outstanding Builders of Socialism with Chinese Characteristics in the New Era "and other awards.2021 is the first year of the "14th Five-Year Plan". In this year's "Two Sessions", carbon peak, carbon neutrality, digital transformation and green development were highlighted. Standing in a new historical window, Jiang Xiaomeng has a preliminary idea for the future development of the peak. In the future, Jianfeng Group will use its advantages in brand, technology, management, and capital to achieve layout optimization, control resources, occupy the market, and become bigger and stronger. At the same time, in the pharmaceutical sector, we will increase the development of new products with high added value, form a product line of antibiotics, cardiovascular and cerebrovascular drugs, safe drugs for infants and young children, antineoplastic drugs and health products, and occupy the forefront of the pharmaceutical industry. Jiang Xiaomeng said that both cement and medicine are closely related to social economy and people's livelihood. Jianfeng Group's extreme pursuit of the two major industries is not only the need of enterprise development, but also the responsibility of exerting enterprise value and benefiting one party.
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page